The Clinical Significance of Preformed C1q-binding Donor-specific HLA Antibodies in Kidney Transplantation

被引：0
|
作者：
Lee, S. [1 ]
Yang, C. [2 ]
Chung, B. [2 ]
机构：
[1] Seoul Natl Univ Hosp, Seoul, South Korea
[2] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Seoul, South Korea
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2021年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
1035
引用
收藏
页码：732 / 732
页数：1
相关论文
共 50 条
  • [21] From Mean Fluorescence Intensity to C1q-Binding: The Saga of Anti-HLA Donor-specific Antibodies
    Loupy, Alexandre
    Legendre, Christophe
    TRANSPLANTATION, 2015, 99 (06) : 1107 - 1108
  • [22] Clinical impact of preformed donor-specific denatured class I HLA antibodies after kidney transplantation
    Visentin, Jonathan
    Marroc, Melanie
    Guidicelli, Gwendaline
    Bachelet, Thomas
    Thoa Nong
    Moreau, Jean-Francois
    Lee, Jar-How
    Merville, Pierre
    Couzi, Lionel
    Taupin, Jean-Luc
    CLINICAL TRANSPLANTATION, 2015, 29 (05) : 393 - 402
  • [23] REASSESSMENT OF THE CLINICAL IMPACT OF PREFORMED DONOR-SPECIFIC ANTI-HLA CW ANTIBODIES IN KIDNEY TRANSPLANTATION
    Visentin, J.
    Bachelet, T.
    Aubert, O.
    Del Bello, A.
    Martinez, C.
    Jambon, F.
    Guidicelli, G.
    Ralazamahaleo, M.
    Bouthemy, C.
    Cargou, M.
    Congy-Jolivet, N.
    Nong, T.
    Lee, J. H.
    Sberro-Soussan, R.
    Couzi, L.
    Kamar, N.
    Legendre, C.
    Merville, P.
    Taupin, J. L.
    TRANSPLANT INTERNATIONAL, 2019, 32 : 6 - 6
  • [24] Reassessment of the clinical impact of preformed donor-specific anti-HLA-Cw antibodies in kidney transplantation
    Visentin, Jonathan
    Bachelet, Thomas
    Aubert, Olivier
    Del Bello, Arnaud
    Martinez, Charlie
    Jambon, Frederic
    Guidicelli, Gwendaline
    Ralazamahaleo, Mamy
    Bouthemy, Charlene
    Cargou, Marine
    Congy-Jolivet, Nicolas
    Nong, Thoa
    Lee, Jar-How
    Sberro-Soussan, Rebecca
    Couzi, Lionel
    Kamar, Nassim
    Legendre, Christophe
    Merville, Pierre
    Taupin, Jean-Luc
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 (05) : 1365 - 1374
  • [25] Role of C1q-Binding Donor-Specific Anti-HLA Antibodies in Premature and Accelerated Kidney Allograft Interstitial Fibrosis.
    Louis, K.
    Viglietti, D.
    Aubert, O.
    Loupy, A.
    Lefaucheur, C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 442 - 442
  • [26] De novo donor-specific anti-HLA antibodies after kidney transplantation are associated with impaired graft outcome independently of their C1q-binding ability
    Kauke, Teresa
    Oberhauser, Cornelia
    Lin, Viviane
    Coenen, Michaela
    Fischereder, Michael
    Dick, Andrea
    Schoenermarck, Ulf
    Guba, Markus
    Andrassy, Joachim
    Werner, Jens
    Meiser, Bruno
    Angele, Martin
    Stangl, Manfred
    Habicht, Antje
    TRANSPLANT INTERNATIONAL, 2017, 30 (04) : 360 - 370
  • [27] CLINICAL SIGNIFICANCE OF COMPLEMENT-BINDING DONOR-SPECIFIC ANTIBODIES AFTER KIDNEY TRANSPLANTATION
    Rodova, Marketa
    Fornbaumova, Iva
    Janatova, Katerina
    Sekerkova, Zuzana
    Slavcev, Antonij
    HLA, 2017, 89 (06) : 404 - 405
  • [28] STRENGTH/SPECIFICITY OF DE NOVO HLA DONOR-SPECIFIC ANTIBODIES IN KIDNEY TRANSPLANTATION: CLINICAL SIGNIFICANCE
    Piazza, Antonina
    Poggi, Elvira
    Ozzella, Giuseppina
    Adorno, Domenico
    HUMAN IMMUNOLOGY, 2009, 70 : S64 - S64
  • [29] CLINICAL OUTCOMES OF KIDNEY TRANSPLANT RECIPIENTS WITH C1Q-BINDING DE NOVO DONOR-SPECIFIC ANTIBODIES: A SINGLE-CENTER EXPERIENCE
    Marinaki, Smaragdi
    Vittoraki, Angeliki G.
    Tsiakas, Stathis
    Kofotolios, Ioannis
    Darema, Maria
    Ioannou, Sofia
    Vallianou, Kalliopi
    Boletis, John
    TRANSPLANT INTERNATIONAL, 2021, 34 : 250 - 250
  • [30] Successful Eradication of De Novo C1q-Binding Donor-Specific Antibodies with Rituximab Monotherapy
    Moghbeli, K.
    Xu, Q.
    Zeevi, A.
    Morrell, M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2021, 40 (04): : S508 - S508
12345